drugset / Trial / NCT00711841

Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome

NCT00711841 ↗

Phase 4 Terminated 400 enrolled Instituto Materno Infantil Prof. Fernando Figueira
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Corticotherapy accelerates maternal postpartum recovery in women with class I HELLP syndrome. The benefit of faster and better recovery would be observed in fewer complications, less utilization of blood products and shorter hospital stay.

Timeline

Start
2011-07
Primary completion
2019-06
Completion
2019-06

Outcome

Outcome not reported

Stopped (Enrollment): “The speed of recruitment was slower than anticipated.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 10 mg Intravenous

Indications